|
|
|
|
HCV TREATMENT AMONG FENTANYL USERS:
TOWARD UNIVERSAL ACROSS TO ANTIVIRAL THERAPY
|
|
|
AASLD 2022 Nov 4-8
Truong D1 , Shawn S1 , Yung R1 , Liu G1 , Conway B 1,2
1 Vancouver Infectious Diseases Centre, Vancouver, Canada 2 Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
|
|
|
|
|
|
|